Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 09:36 am Sale |
2024-09-30 | 13G | Halozyme Therapeutics, Inc. HALO |
Artisan Partners Limited Partnership | 3,133,412 2.500% |
-3,555,646 (-53.16%) |
Filing History |
| 2024-10-17 09:36 am Purchase |
2024-09-30 | 13G | Halozyme Therapeutics, Inc. HALO |
STATE STREET CORP STT |
6,635,827 5.200% |
6,635,827 (New Position) |
Filing History |
| 2024-02-13 5:06 pm Sale |
2023-12-29 | 13G | Halozyme Therapeutics, Inc. HALO |
The Vanguard Group | 13,259,514 10.040% |
-269,116 (-1.99%) |
Filing History |
| 2024-02-12 06:19 am Sale |
2023-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
Artisan Partners Limited Partnership | 6,689,058 5.100% |
-451,895 (-6.33%) |
Filing History |
| 2024-02-01 3:51 pm Sale |
2024-02-01 | 13G | Halozyme Therapeutics, Inc. HALO |
Invesco Ltd. IVZ |
2,816,427 2.100% |
-4,220,524 (-59.98%) |
Filing History |
| 2024-01-23 11:52 am Sale |
2023-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
BLACKROCK INC BLK |
18,629,818 14.100% |
-566,243 (-2.95%) |
Filing History |
| 2023-06-09 2:15 pm Purchase |
2023-05-31 | 13G | Halozyme Therapeutics, Inc. HALO |
The Vanguard Group | 13,528,630 10.270% |
224,783 (+1.69%) |
Filing History |
| 2023-02-10 2:11 pm Unchanged |
2022-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
BLACKROCK INC BLK |
19,196,061 14.200% |
0 (Unchanged) |
Filing History |
| 2023-02-10 09:00 am Sale |
2022-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
Artisan Partners Limited Partnership | 7,140,953 5.300% |
-2,364,815 (-24.88%) |
Filing History |
| 2023-02-09 6:35 pm Purchase |
2023-02-08 | 13G | Halozyme Therapeutics, Inc. HALO |
Invesco Ltd. IVZ |
7,036,951 5.200% |
7,036,951 (New Position) |
Filing History |
| 2023-02-09 11:22 am Sale |
2022-12-30 | 13G | Halozyme Therapeutics, Inc. HALO |
The Vanguard Group | 13,303,847 9.840% |
-238,742 (-1.76%) |
Filing History |
| 2023-01-26 08:52 am Purchase |
2022-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
BLACKROCK INC BLK |
19,196,061 13.600% |
981,990 (+5.39%) |
Filing History |
| 2023-01-20 3:00 pm Sale |
2022-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
BLACKROCK INC BLK |
18,214,071 13.600% |
-1,225,792 (-6.31%) |
Filing History |
| 2022-12-12 3:09 pm Purchase |
2022-11-30 | 13G | Halozyme Therapeutics, Inc. HALO |
The Vanguard Group | 13,542,589 10.020% |
46,676 (+0.35%) |
Filing History |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
The Vanguard Group | 13,495,913 9.590% |
346,210 (+2.63%) |
Filing History |
| 2022-02-04 06:15 am Sale |
2021-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
Artisan Partners Limited Partnership | 9,505,768 6.800% |
-778,368 (-7.57%) |
Filing History |
| 2022-01-28 1:54 pm Purchase |
2021-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
BLACKROCK INC BLK |
19,439,863 13.800% |
958,556 (+5.19%) |
Filing History |
| 2021-02-12 5:01 pm Sale |
2020-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
BB BIOTECH AG | 3,970,000 2.900% |
-3,993,056 (-50.14%) |
Filing History |
| 2021-02-10 10:57 am Sale |
2020-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
The Vanguard Group | 13,149,703 9.730% |
-873,756 (-6.23%) |
Filing History |
| 2021-02-10 06:17 am Sale |
2020-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
Artisan Partners Limited Partnership | 10,284,136 7.600% |
-4,145,901 (-28.73%) |
Filing History |